mRNA-1273 Clinical Trials
2 recruitingBiologic
Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 4
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
ModernaTX, Inc.30,000 enrolled150 locationsNCT07266558
Recruiting
COVID-19 Vaccines Safety Tracking (CoVaST)
Adverse Reaction to VaccineCOVID19 Vaccine
Masaryk University30,000 enrolled14 locationsNCT04834869